Company intelligence / Profile preview

NimbleHeart

Sunnyvale, California, USAnimbleheart.com ↗

Ownership: Private
Employees: ~7
Development stage: Commercial

Overview

NimbleHeart has developed an FDA-approved wearable ECG harness using proprietary dry electrode technology for real-time and post-session remote cardiac monitoring. The system is used in both primary and secondary preventive care settings. It enables hands-free, adhesive-free long-term ECG recording with cloud-based physician review. The company has delivered devices to NASA and launched preventive screening programs as of 2024

Therapeutic areas: Cardiovascular
Modalities: DeviceDigital health platformWearable medical device
Industry: Physiological Monitoring

Partnerships

NASA Ames Research Center—delivered custom versions of the ECG harnesses to NASA for research use.No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on NimbleHeart.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NimbleHeart.

Explore the full profile